Man Chen, Jing Zhou, Wei Zhao, Jing Long, Minjing Fu, Xian Zhang et al. CD72 as a complementary B‐lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR‐T therapy in R/R B‐ALL. // Cytometry Part B - Clinical Cytometry. – 2026. – DOI: 10.1002/cyto.b.70057. – URL: https://onlinelibrary.wiley.com/doi/10.1002/cyto.b.70057?af=R
Man Chen, Jing Zhou, Wei Zhao, Jing Long, Minjing Fu, Xian Zhang, Yi Li, Gailing Zhang, & Hui Wang (2026). CD72 as a complementary B‐lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR‐T therapy in R/R B‐ALL. Cytometry Part B - Clinical Cytometry. https://doi.org/10.1002/cyto.b.70057
Man Chen, et al. “CD72 as a complementary B‐lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR‐T therapy in R/R B‐ALL.” Cytometry Part B - Clinical Cytometry, 2026. doi:10.1002/cyto.b.70057.
@article{Chen2026,
title = {CD72 as a complementary B‐lineage marker for longitudinal measurable residual disease surveillance after CD19 CAR‐T therapy in R/R B‐ALL},
author = {Chen, Man and Zhou, Jing and Zhao, Wei and Long, Jing and Fu, Minjing and Zhang, Xian and Li, Yi and Zhang, Gailing and Wang, Hui},
journal = {Cytometry Part B - Clinical Cytometry},
year = {2026},
doi = {10.1002/cyto.b.70057},
url = {https://onlinelibrary.wiley.com/doi/10.1002/cyto.b.70057?af=R}
}